Search

Search Constraints

You searched for: Author/Creator Halfvarson, Jonas

Search Results

81. The Gut Microbiota in Collagenous Colitis Shares Characteristics With Inflammatory Bowel Disease-Associated Dysbiosis. Issue 7 (July 2019)

82. The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up – an Epi-IBD study. Issue 8 (October 2020)

83. The use of 5‐aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow‐up – an Epi‐IBD study. Issue 8 (1st October 2020)

84. The use of ICD codes to identify IBD subtypes and phenotypes of the Montreal classification in the Swedish National Patient Register. (2nd April 2020)

85. Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development. (April 2019)

86. Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register. Issue 7 (14th July 2022)

87. Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG). (1st February 2017)

89. Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study. Issue 11 (November 2018)

90. Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial. (March 2023)